CHARACTERIZATION OF A RECEPTOR FOR INTERLEUKIN-5 ON HUMAN EOSINOPHILS - VARIABLE EXPRESSION AND INDUCTION BY GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR

被引:103
作者
CHIHARA, J
PLUMAS, J
GRUART, V
TAVERNIER, J
PRIN, L
CAPRON, A
CAPRON, M
机构
[1] INST PASTEUR,CTR IMMUNOL & BIOL PARASITAIRE,CNRS,UNITE MIXTE 624,INSERM,U167,F-59019 LILLE,FRANCE
[2] ROCHE RES GENT,B-9000 GHENT,BELGIUM
关键词
D O I
10.1084/jem.172.5.1347
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 5 (IL5) acts on eosinophil differentiation and activation, suggesting the existence of a membrane receptor for IL5 on eosinophils. Here, we report that 125I-labeled recombinant human 11,5 bound, at 4°C, to high affinity receptors on human eosinophils. The association constant was higher for hypodense eosinophils (1.93 × 109 M−1) than for normodense cells (0.39 × 109 M−1), with a closely related number of receptor sites per cell. No specific binding occurred on neutrophils. The specific binding of 1165 was induced by overnight incubation at 37°C of human eosinophils with granulocyte/macrophage (GM)-CSF. The levels of increase were significantly higher for normodense than for hypodense eosinophils, suggesting a previous in vivo activation of the later subpopulation by GM-CSF 1173 was ineffective by itself but synergistically enhanced the effect of GM-CSF. Specificity studies showed that the binding of 125I-labeled IL5 was inhibited by 116, but not by other cytokines, on human eosinophils. These results show the existence of a specific binding site for IL5 on human eosinophils with a variable affinity on eosinophil hypodense or normodense subpopulations, as previously reported for other membrane receptors. © 1990, Rockefeller University Press., All rights reserved.
引用
收藏
页码:1347 / 1351
页数:5
相关论文
共 13 条
[1]  
CAPRON M, 1987, J IMMUNOL, V139, P2059
[2]  
CAPRON M, 1984, J IMMUNOL, V132, P462
[3]   INDUCTION OF HYPODENSE EOSINOPHILS AND NUCLEAR HYPERSEGMENTATION OF EOSINOPHILS BY VARIOUS CHEMOTACTIC FACTORS AND LYMPHOKINES INVITRO [J].
CHIHARA, J ;
NAKAJIMA, S .
ALLERGY PROCEEDINGS, 1989, 10 (01) :27-32
[4]  
CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504
[5]  
GRUART V, 1989, J IMMUNOL, V142, P4416
[6]   RECIPROCAL INHIBITION OF BINDING BETWEEN INTERLEUKIN-3 AND GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR TO HUMAN EOSINOPHILS [J].
LOPEZ, AF ;
EGLINTON, JM ;
GILLIS, D ;
PARK, LS ;
CLARK, S ;
VADAS, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :7022-7026
[7]  
LOWENTHAL JW, 1988, J IMMUNOL, V140, P456
[8]   RECEPTORS FOR T-CELL-REPLACING FACTOR INTERLEUKIN-5 - SPECIFICITY, QUANTITATION, AND ITS IMPLICATION [J].
MITA, S ;
HARADA, N ;
NAOMI, S ;
HITOSHI, Y ;
SAKAMOTO, K ;
AKAGI, M ;
TOMINAGA, A ;
TAKATSU, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (03) :863-878
[9]   INTERLEUKIN-5 AND PHENOTYPICALLY ALTERED EOSINOPHILS IN THE BLOOD OF PATIENTS WITH THE IDIOPATHIC HYPEREOSINOPHILIC SYNDROME [J].
OWEN, WF ;
ROTHENBERG, ME ;
PETERSEN, J ;
WELLER, PF ;
SILBERSTEIN, D ;
SHEFFER, AL ;
STEVENS, RL ;
SOBERMAN, RJ ;
AUSTEN, KF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (01) :343-348
[10]  
PRIN L, 1984, CLIN EXP IMMUNOL, V57, P735